Quince Therapeutics, Inc. - 8-K Filing
Quince Therapeutics acquired Orphai Therapeutics for $115M upfront and potential additional proceeds from warrants.
Tickers: $QNCX
Quince Therapeutics acquired Orphai Therapeutics for $115M upfront and potential additional proceeds from warrants.
Tickers: $QNCX